The AHR-activating potential (AHR-AP) of the CKD patients’ serum, reflecting the serum’s ability to activate AHR ex vivo, was increased compared with the control subjects and correlated with the glomerular filtration rate and serum levels of indoxyl sulfate [155]. This evidence concerns the gene AHR and chronic kidney disease.